BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Europe/Berlin
LAST-MODIFIED:20250410T142247Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Europe/Berlin
X-LIC-LOCATION:Europe/Berlin
BEGIN:DAYLIGHT
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
DTSTART:19700329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
DTSTART:19701025T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260925T143129Z
DTSTART;TZID=Europe/Berlin:20261008T121500
DTEND;TZID=Europe/Berlin:20261008T133000
SUMMARY:Advanced heart failure in 2026: The expanding role of LVAD therapy
DESCRIPTION:Faculty: V. Falk\, J. González-Costello\, G. Färber\, Z. Kohistani\, J. Riebandt\, C. Schulze\n\nLearning Objectives:\n\nHow to close the gap between practice and the 2026 ESC HF guidelines for advanced heart failure management\n\nExplore how the timing of advanced heart failure evaluation influences candidacy and outcomes for advanced surgical therapies\n\nDiscuss the evolving role of LVAD therapy across the advanced heart failure continuum\n\nExamine the evidence demonstrating the ability of durable LVAD therapy to prolong life and improve outcomes in advanced heart failure patients\n\nDebate whether current systems\, pathways\, and treatment strategies adequately address the unmet needs of advanced heart failure patients
LOCATION:Room 120-121
END:VEVENT
END:VCALENDAR